Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms

Journal of Hospital Infection

Volumn 70, Issue 4, 2008, Pages 361-368

  Peeters, E ^a   Nelis, H J ^a   Coenye, T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

B. cepacia complex; Biofilm; Disinfectants; Resistance

Indexed keywords

ACETIC ACID; ALCOHOL; CETRIMIDE; CHLORHEXIDINE; CHLOROXYLENOL; CRYSTAL VIOLET; DISINFECTANT AGENT; HOT WATER; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; RESAZURIN;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOPLANKTON; BIOFILM; BIOMASS; BURKHOLDERIA CENOCEPACIA; CELL COUNT; CELL KILLING; CELL SUSPENSION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOCHEMISTRY; DISINFECTION; MEDICAL INSTRUMENTATION; NONHUMAN; SESSILE SPECIES;

BIOFILMS; BURKHOLDERIA CEPACIA COMPLEX; CHLORHEXIDINE; DISINFECTANTS; DISINFECTION; EQUIPMENT AND SUPPLIES, HOSPITAL; EQUIPMENT CONTAMINATION; HUMANS; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; SODIUM HYPOCHLORITE;

EID: 56249119172     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.08.015     Document Type: Article

References (26)

1. Donlan R.M., and Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2001) 167-193
2. Mah T.F.C., and O'Toole G.A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9 (2001) 34-39
3. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 45 (2001) 999-1007
4. Fux C.A., Costerton J.W., Stewart P.S., and Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 13 (2005) 34-40
5. LiPuma J.J. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 11 (2005) 528-533
6. Burns J. Antibiotic resistance of Burkholderia spp. In: Coenye T., and Vandamme P. (Eds). Burkholderia: molecular biology and genomics (2007), Horizon Press, Wymondham 81-91
7. Conway B.A., Venu V., and Speert D.P. Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J Bacteriol 184 (2002) 5678-5685
8. Caraher E., Reynolds G., Murphy P., McClean S., and Callaghan M. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis 26 (2006) 213-216
9. Desai M., Buhler T., Weller P.H., and Brown M.R. Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrob Chemother 42 (1998) 153-160
10. Walsh N.M., Casano A.A., Manangan L.P., Sinkowitz-Cochran R.L., and Jarvis W.R. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. J Pediatr 141 (2002) 512-517
11. Mahenthiralingam E., Urban T.A., and Goldberg J.B. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3 (2005) 144-156
12. Saiman L., and Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 17 (2004) 57-71
13. Hutchinson G.R., Parker S., Pryor J.A., et al. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, Gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 34 (1996) 584-587
14. Vassal S., Taamma R., Marty N., et al. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. Am J Infect Control 28 (2000) 347-351
15. Luppens S.B.I., Reij M.W., van der Heijden R.W.L., Rombouts F.M., and Abee T. Development of a standard test to assess the resistance of Staphylococcus aureus biofilm cells to disinfectants. Appl Environ Microbiol 68 (2002) 4194-4200
16. Mahenthiralingam E., Coenye T., Chung J.W., et al. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38 (2001) 910-913
17. Anonymous. Chemical disinfectants and antiseptics - basic bactericidal activity-test method and requirement (phase 1) EN-1040 (1997), Nederlands Normalisatie Instituut, Delft
18. Stickler D.J. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol Symposium Suppl 92 (2002) 1663S-1670S
19. Miyano N., Oie S., and Kamiya A. Efficacy of disinfectants and hot water against biofilm cells of Burkholderia cepacia. Biol Pharm Bull 26 (2003) 671-674
20. Hugo W.B., Pallent L.J., Grant D.J.W., Denyer S.P., and Davies A. Factors contributing to the survival of a strain of Pseudomonas cepacia in chlorhexidine solutions. Lett Appl Microbiol 2 (1986) 37-42
21. Stewart P.S., Roe F., Elkins J.G., Lewandowski Z., Ochsner U.A., and Hasset D.J. Effect of catalase on hydrogen peroxide penetration into Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 66 (2000) 836-838
22. Lefebre M.D., and Valvano M.A. In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production. Microbiology 147 (2001) 97-109
23. Lefebre M.D., Flannagan R.S., and Valvano M.A. A minor catalase/peroxidase from Burkholderia cenocepacia is required for normal aconitase activity. Microbiology 151 (2005) 1975-1985
24. Charalabous P., Risk J.M., Jankins R., Birss A.J., Hart A., and Smalley J.W. Characterization of a bifunctional catalase-peroxidase of Burkholderia cenocepacia. FEMS Immunol Med Microbiol 50 (2007) 37-44
25. Vreys M., Proesmans M., and De Boeck K. Cleaning of positive expiratory pressure mask: an investigation of patient routines. J Cyst Fibros 5 (2006) S80
26. Lester K.M., Flume P.A., Gray S.L., Anderson D., and Bowman C.M. Nebulizer use and maintenance by cystic fibrosis patients: a survey study. Respir Care 49 (2004) 1504-1508